QUADRISE PLC — Share Issue/Capital Change 2019

Sep 27, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0184O

Quadrise Fuels International PLC

27 September 2019

27 September 2019

Quadrise Fuels International plc

("Quadrise", "QFI" or "the Company")

Issue of Warrants

The Company announces that, following the general meeting of the Company held on 27 September 2019, the Company has today issued 4,900,000 warrants to subscribe for new ordinary shares in the Company, at any point until 36 months from the date of issue, at a current exercise price of 5.78 pence per new ordinary share pursuant to, and on and subject to the terms and conditions set out in, a warrant instrument dated 27 September 2019, the details of which were announced by the Company on 23 August 2019.

For further information, please refer to the Company's website at www.quadrisefuels.com, or contact [email protected] or phone:

Quadrise Fuels International Plc
Mike Kirk, Executive Chairman	+44 (0)20 7031 7321
Jason Miles, Chief Operating Officer
Nominated Adviser
Cenkos Securities plc
Dr Azhic Basirov	+44 (0)20 7397 8900
Ben Jeynes Katy Birkin
Joint Brokers
Peel Hunt LLP
Richard Crichton	+44 (0)20 7418 8900
Ross Allister
Shore Capital Stockbrokers Limited
Daniel Harris Andy Crossley	+44 (0)20 7601 6108
Public & Investor Relations
FTI Consulting
Ben Brewerton	+44 (0)20 3727 1000
Ntobeko Chidavaenzi

Notes to Editors

QFI is the supplier of MSAR® emulsion technology and fuels, a low-cost alternative to heavy fuel oil (one of the world's largest fuel markets, comprising over 450 million tons per annum) in the global shipping, refining and steam and power generation industries.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IODPGUCUBUPBGAM